table of content
1 Introduction to Research & Analysis Reports
1.1 Viral Vector and Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vector and Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vector and Vaccine Overall Market Size
2.1 Global Viral Vector and Vaccine Market Size: 2023 VS 2030
2.2 Global Viral Vector and Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Viral Vector and Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top Viral Vector and Vaccine Players in Global Market
3.2 Top Global Viral Vector and Vaccine Companies Ranked by Revenue
3.3 Global Viral Vector and Vaccine Revenue by Companies
3.4 Global Viral Vector and Vaccine Sales by Companies
3.5 Global Viral Vector and Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Viral Vector and Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Viral Vector and Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Viral Vector and Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Viral Vector and Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Viral Vector and Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vector and Vaccine Market Size Markets, 2023 & 2030
4.1.2 Adenovirus
4.1.3 Fowlpox Virus
4.1.4 Attenuated Yellow Fever
4.1.5 Vaccinia Virus Vectors
4.2 By Type - Global Viral Vector and Vaccine Revenue & Forecasts
4.2.1 By Type - Global Viral Vector and Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Viral Vector and Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global Viral Vector and Vaccine Sales & Forecasts
4.3.1 By Type - Global Viral Vector and Vaccine Sales, 2019-2024
4.3.2 By Type - Global Viral Vector and Vaccine Sales, 2025-2030
4.3.3 By Type - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global Viral Vector and Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vector and Vaccine Market Size, 2023 & 2030
5.1.2 Research Institutes
5.1.3 Biopharmaceutical Companies
5.1.4 Others
5.2 By Application - Global Viral Vector and Vaccine Revenue & Forecasts
5.2.1 By Application - Global Viral Vector and Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Viral Vector and Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global Viral Vector and Vaccine Sales & Forecasts
5.3.1 By Application - Global Viral Vector and Vaccine Sales, 2019-2024
5.3.2 By Application - Global Viral Vector and Vaccine Sales, 2025-2030
5.3.3 By Application - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global Viral Vector and Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Viral Vector and Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Viral Vector and Vaccine Revenue & Forecasts
6.2.1 By Region - Global Viral Vector and Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Viral Vector and Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Viral Vector and Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global Viral Vector and Vaccine Sales & Forecasts
6.3.1 By Region - Global Viral Vector and Vaccine Sales, 2019-2024
6.3.2 By Region - Global Viral Vector and Vaccine Sales, 2025-2030
6.3.3 By Region - Global Viral Vector and Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Viral Vector and Vaccine Revenue, 2019-2030
6.4.2 By Country - North America Viral Vector and Vaccine Sales, 2019-2030
6.4.3 US Viral Vector and Vaccine Market Size, 2019-2030
6.4.4 Canada Viral Vector and Vaccine Market Size, 2019-2030
6.4.5 Mexico Viral Vector and Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Viral Vector and Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe Viral Vector and Vaccine Sales, 2019-2030
6.5.3 Germany Viral Vector and Vaccine Market Size, 2019-2030
6.5.4 France Viral Vector and Vaccine Market Size, 2019-2030
6.5.5 U.K. Viral Vector and Vaccine Market Size, 2019-2030
6.5.6 Italy Viral Vector and Vaccine Market Size, 2019-2030
6.5.7 Russia Viral Vector and Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries Viral Vector and Vaccine Market Size, 2019-2030
6.5.9 Benelux Viral Vector and Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Viral Vector and Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia Viral Vector and Vaccine Sales, 2019-2030
6.6.3 China Viral Vector and Vaccine Market Size, 2019-2030
6.6.4 Japan Viral Vector and Vaccine Market Size, 2019-2030
6.6.5 South Korea Viral Vector and Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia Viral Vector and Vaccine Market Size, 2019-2030
6.6.7 India Viral Vector and Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Viral Vector and Vaccine Revenue, 2019-2030
6.7.2 By Country - South America Viral Vector and Vaccine Sales, 2019-2030
6.7.3 Brazil Viral Vector and Vaccine Market Size, 2019-2030
6.7.4 Argentina Viral Vector and Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Viral Vector and Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Viral Vector and Vaccine Sales, 2019-2030
6.8.3 Turkey Viral Vector and Vaccine Market Size, 2019-2030
6.8.4 Israel Viral Vector and Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia Viral Vector and Vaccine Market Size, 2019-2030
6.8.6 UAE Viral Vector and Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 ABL
7.1.1 ABL Company Summary
7.1.2 ABL Business Overview
7.1.3 ABL Viral Vector and Vaccine Major Product Offerings
7.1.4 ABL Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 ABL Key News & Latest Developments
7.2 Addgene
7.2.1 Addgene Company Summary
7.2.2 Addgene Business Overview
7.2.3 Addgene Viral Vector and Vaccine Major Product Offerings
7.2.4 Addgene Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 Addgene Key News & Latest Developments
7.3 Aldevron
7.3.1 Aldevron Company Summary
7.3.2 Aldevron Business Overview
7.3.3 Aldevron Viral Vector and Vaccine Major Product Offerings
7.3.4 Aldevron Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 Aldevron Key News & Latest Developments
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Company Summary
7.4.2 Boehringer Ingelheim International GmbH Business Overview
7.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Major Product Offerings
7.4.4 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
7.5 Brammer Bio
7.5.1 Brammer Bio Company Summary
7.5.2 Brammer Bio Business Overview
7.5.3 Brammer Bio Viral Vector and Vaccine Major Product Offerings
7.5.4 Brammer Bio Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 Brammer Bio Key News & Latest Developments
7.6 Charles River Laboratories
7.6.1 Charles River Laboratories Company Summary
7.6.2 Charles River Laboratories Business Overview
7.6.3 Charles River Laboratories Viral Vector and Vaccine Major Product Offerings
7.6.4 Charles River Laboratories Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Charles River Laboratories Key News & Latest Developments
7.7 Creative-Biogene
7.7.1 Creative-Biogene Company Summary
7.7.2 Creative-Biogene Business Overview
7.7.3 Creative-Biogene Viral Vector and Vaccine Major Product Offerings
7.7.4 Creative-Biogene Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Creative-Biogene Key News & Latest Developments
7.8 Fujifilm Corporation
7.8.1 Fujifilm Corporation Company Summary
7.8.2 Fujifilm Corporation Business Overview
7.8.3 Fujifilm Corporation Viral Vector and Vaccine Major Product Offerings
7.8.4 Fujifilm Corporation Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.8.5 Fujifilm Corporation Key News & Latest Developments
7.9 General Electric
7.9.1 General Electric Company Summary
7.9.2 General Electric Business Overview
7.9.3 General Electric Viral Vector and Vaccine Major Product Offerings
7.9.4 General Electric Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.9.5 General Electric Key News & Latest Developments
7.10 MerckKGaA
7.10.1 MerckKGaA Company Summary
7.10.2 MerckKGaA Business Overview
7.10.3 MerckKGaA Viral Vector and Vaccine Major Product Offerings
7.10.4 MerckKGaA Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.10.5 MerckKGaA Key News & Latest Developments
7.11 Novasep
7.11.1 Novasep Company Summary
7.11.2 Novasep Viral Vector and Vaccine Business Overview
7.11.3 Novasep Viral Vector and Vaccine Major Product Offerings
7.11.4 Novasep Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.11.5 Novasep Key News & Latest Developments
7.12 Pfizer
7.12.1 Pfizer Company Summary
7.12.2 Pfizer Viral Vector and Vaccine Business Overview
7.12.3 Pfizer Viral Vector and Vaccine Major Product Offerings
7.12.4 Pfizer Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.12.5 Pfizer Key News & Latest Developments
7.13 Spark Therapeutics
7.13.1 Spark Therapeutics Company Summary
7.13.2 Spark Therapeutics Viral Vector and Vaccine Business Overview
7.13.3 Spark Therapeutics Viral Vector and Vaccine Major Product Offerings
7.13.4 Spark Therapeutics Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.13.5 Spark Therapeutics Key News & Latest Developments
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Company Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Major Product Offerings
7.14.4 Thermo Fisher Scientific Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.14.5 Thermo Fisher Scientific Key News & Latest Developments
7.15 Waisman Biomanufacturing
7.15.1 Waisman Biomanufacturing Company Summary
7.15.2 Waisman Biomanufacturing Business Overview
7.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Major Product Offerings
7.15.4 Waisman Biomanufacturing Viral Vector and Vaccine Sales and Revenue in Global (2019-2024)
7.15.5 Waisman Biomanufacturing Key News & Latest Developments
8 Global Viral Vector and Vaccine Production Capacity, Analysis
8.1 Global Viral Vector and Vaccine Production Capacity, 2019-2030
8.2 Viral Vector and Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Viral Vector and Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Viral Vector and Vaccine Supply Chain Analysis
10.1 Viral Vector and Vaccine Industry Value Chain
10.2 Viral Vector and Vaccine Upstream Market
10.3 Viral Vector and Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Viral Vector and Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
